RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Susan Wojcicki
S

Susan Wojcicki portfolio

Susan Wojcicki has 2 portfolio companies on record at Recent Funding.

Type: Angel investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $324M.
Latest deal: Midi Health · Apr 24, 2024.
About this page

It is an angel investor. Its most recent investment on record is Midi Health's $60M Series B+ round in April 2024, alongside Emerson Collective, Tory Burch, SemperVirens and 7 others. By category, its portfolio leans toward Health and bio (1) and Commerce and retail (1). It has co-invested with Operator Collective, SemperVirens and Icon Ventures, most often Operator Collective (2 rounds).

What Susan Wojcicki invests in

Susan Wojcicki recent investments

CompanyRoundDateAlongside
MMidi HealthSeries B+ · $60MEmerson Collective (lead), Tory Burch, SemperVirens +7
MMidi HealthSeed · $14Mf7 Ventures, G9 Ventures, SemperVirens (lead) +6
AApeel SciencesSeries B+ · $250MViking Global Investors, Tao Capital, Sweetwater Capital Partners +5

How Susan Wojcicki invests

StageDealsCapital in rounds
Series B+ 2 67%$310M
Seed 1 33%$14M
YearDealsCapital in rounds
2021 1 33%$250M
2022 1 33%$14M
2024 1 33%$60M

Susan Wojcicki portfolio companies

CompanyRound with Susan WojcickiTotal raisedLatest raise
MMidi Health
Health and bio
Series B+ · $60M$249MMar 17, 2026
Series B+
AApeel Sciences
Commerce and retail
Series B+ · $250M$603MOct 22, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name Susan Wojcicki. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Susan Wojcicki, which is a subset of its real portfolio. API: /api/v1/investors/susan-wojcicki (get a free API key). More: the most active VC firms and new venture capital funds.